Cooper University Hospital Infectious Disease

Fellowship · Camden, NJ

Sponsored by Cooper Medical School of Rowan University/Cooper University Hospital · Director Rosalie Pepe

Works by its people: 171
Authors: 20
First-author works: 38
Citations: 5,034

20112026

Topics

HIV/AIDS drug development and treatment 28
Antibiotic Resistance in Bacteria 12
HIV Research and Treatment 10
Antimicrobial Resistance in Staphylococcus 8
Antifungal resistance and susceptibility 6
Neurotransmitter Receptor Influence on Behavior 4
Tuberculosis Research and Epidemiology 4
Antibiotic Use and Resistance 3
HIV/AIDS Research and Interventions 3
HIV-related health complications and treatments 3
Infective Endocarditis Diagnosis and Management 3
Influenza Virus Research Studies 3

Most cited

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024.
Open forum infectious diseases · 2025 · 11 citations · John Baxter
Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993-2019.
Open forum infectious diseases · 2024 · 7 citations · Henry Fraimow
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations.
JACC. Advances · 2024 · 13 citations · Rosalie Pepe
Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates.
Antibiotics (Basel, Switzerland) · 2022 · 19 citations · Henry Fraimow
Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance.
Antibiotics (Basel, Switzerland) · 2022 · 16 citations · Henry Fraimow, Raquel Nahra
Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
HIV medicine · 2021 · 19 citations · John Baxter
Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
HIV medicine · 2024 · 5 citations · John Baxter
Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report.
Therapeutic advances in infectious disease · 2023 · 6 citations · Katherine Doktor

Topics

HIV/AIDS drug development and treatment 28

Antibiotic Resistance in Bacteria 12

HIV Research and Treatment 10

Antimicrobial Resistance in Staphylococcus 8

Antifungal resistance and susceptibility 6

Neurotransmitter Receptor Influence on Behavior 4

Tuberculosis Research and Epidemiology 4

Antibiotic Use and Resistance 3

HIV/AIDS Research and Interventions 3

HIV-related health complications and treatments 3

Infective Endocarditis Diagnosis and Management 3

Influenza Virus Research Studies 3

Most cited

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024.

Open forum infectious diseases · 2025 · 11 citations · John Baxter

Epidemiology and Clinical Characteristics of Ocular Tuberculosis in the United States, 1993-2019.

Open forum infectious diseases · 2024 · 7 citations · Henry Fraimow

Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations.

JACC. Advances · 2024 · 13 citations · Rosalie Pepe

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates.

Antibiotics (Basel, Switzerland) · 2022 · 19 citations · Henry Fraimow

Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance.

Antibiotics (Basel, Switzerland) · 2022 · 16 citations · Henry Fraimow, Raquel Nahra

Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.

HIV medicine · 2021 · 19 citations · John Baxter

Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.

HIV medicine · 2024 · 5 citations · John Baxter

Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report.

Therapeutic advances in infectious disease · 2023 · 6 citations · Katherine Doktor